Europe Initiates Effort to Develop Independent Biomedical Research Databases

Pubmed, managed and funded by the US National Library of Medicine, remains the world's foremost biomedical literature database, heavily used by millions of European researchers, students, and doctors. However, reliance on this US-controlled resource raises critical concerns over scientific integrity and political influence. In April 2025, the US National Institutes of Health (NIH) restricted access to certain biomedical databases for selected countries, demonstrating how geopolitical decisions can disrupt scientific research access.

Europe, recognizing these vulnerabilities, aims to reduce dependency on US infrastructure by developing its own biomedical databases. The Olspub initiative, spearheaded by the German research library Zentralbibliothek Medizin (ZB Med), is focused on creating an independent European platform that stores scientific articles from European publishers on European servers. This project seeks to safeguard research continuity and mitigate risks associated with current dependencies.

The initiative has set a funding goal of two million euros, with project leader Miriam Albers emphasizing that the effort is a form of risk management rather than an attempt to sever transatlantic collaboration. The disruption of access, even for a week, could have severe economic and health repercussions for medical research and patient care. While Europe PMC mirrors Pubmed's data, it still relies on American collaboration, highlighting the ongoing need for autonomous infrastructure.

Historically, Pubmed stems from the 1800s Index Medicus and represents a collective repository of medical knowledge, but continuing reliance on US systems poses risks. As such, investing in Europe's independent database infrastructure is considered a necessary insurance policy to secure the future of scientific research in the region.